milvexian
bms
['factor xi', 'axiomatic', 'milvexian', '$bmy']
$bmy late-breaking results from phase 2 axiomatic-ssp study of milvexian, an investigational oral factor xia inhibitor, show favorable antithrombotic profile in combination with dual antiplatelet therapy
New to the market?Been in the game for a while?Join our community of over 14,000 investing/trading enthusiasts??Alerts, education, live trading, & more????